Expertise in

conditions

Andres Nascimento

Barcelona, CT, ES

Clinical Trials:Currently Recruiting for 1 Trial

Expertise in

conditions

Barcelona, CT, ES

Overview

Andres Nascimento practices in Barcelona, Spain. Mr. Nascimento is highly rated in 23 conditions, according to our data. His top areas of expertise are Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Duchenne Muscular Dystrophy, and Becker Muscular Dystrophy.

His clinical research consists of co-authoring 124 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Barcelona, CT, Spain

Other Locations

Madrid, MD, Spain

Esplugues De Llobregat, CT, Spain

Sant Joan, PM 08950, Spain

Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies

Enrollment Status: Recruiting

Publish Date: January 21, 2026

Intervention Type: Drug

Study Phase: Phase 2/Phase 3

A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy

Enrollment Status: Completed

Publish Date: November 18, 2025

Intervention Type: Drug

Study Drugs: SRP-4045 Exon 45-Skipping Treatment, SRP-4053 Exon 53-Skipping Treatment

Study Phase: Phase 3

A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)

Enrollment Status: Completed

Publish Date: July 08, 2025

Intervention Type: Genetic

Study Phase: Phase 3

Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy

Enrollment Status: Completed

Publish Date: February 02, 2023

Intervention Type: Drug

Study Drug: Givinostat

Study Phase: Phase 3

Tamoxifen in Duchenne Muscular Dystrophy: A Multicenter, Randomised, Double-blind, Placebo-controlled, Phase 3 Safety and Efficacy 48-week Trial

Enrollment Status: Completed

Publish Date: December 20, 2022

Intervention Type: Drug

Study Drug: Tamoxifen

Study Phase: Phase 3

A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids

Enrollment Status: Terminated

Publish Date: December 03, 2021

Intervention Type: Drug

Study Drug: Idebenone

Study Phase: Phase 3

A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study

Enrollment Status: Terminated

Publish Date: December 03, 2021

Intervention Type: Drug

Study Drug: Idebenone

Study Phase: Phase 3

View 6 Less Clinical Trials

124 Total Publications

Immune-mediated polyneuropathies

Journal: Medicina

Published: October 02, 2025

View All 124 Publications

Frequently Asked Questions about Andres Nascimento

Is Andres Nascimento a top-rated expert for Spinal Muscular Atrophy (SMA)?

MediFind is an objective health platform that identifies experts based on real-world data. Andres Nascimento is classified as an Distinguished expert for Spinal Muscular Atrophy (SMA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andres Nascimento participate in research or clinical trials?

Yes. Andres Nascimento has published 124 articles and abstracts on conditions like Spinal Muscular Atrophy (SMA). You can view a list of Andres Nascimento's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nascimento's expertise for a condition

ConditionClose